Conclusively, HER2-positive breast cancer had a significantly different molecular entity with HER2-low and HER2-zero breast cancer independent of HR status and HER2-low breast cancer and HER2-zero breast cancer shared a similar molecular signature even within the HR+ or HR− subtype. Here, ERBB2 is linked to breast carcinoma.